BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31591481)

  • 1. Oncogenic HOXB8 is driven by MYC-regulated super-enhancer and potentiates colorectal cancer invasiveness via BACH1.
    Ying Y; Wang Y; Huang X; Sun Y; Zhang J; Li M; Zeng J; Wang M; Xiao W; Zhong L; Xu B; Li L; Tao Q; Wang X; Shu XS
    Oncogene; 2020 Jan; 39(5):1004-1017. PubMed ID: 31591481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BACH1 promotes the progression of human colorectal cancer through BACH1/CXCR4 pathway.
    Zhu GD; Liu F; OuYang S; Zhou R; Jiang FN; Zhang B; Liao WJ
    Biochem Biophys Res Commun; 2018 May; 499(2):120-127. PubMed ID: 29481800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberration of Nrf2‑Bach1 pathway in colorectal carcinoma; role in carcinogenesis and tumor progression.
    El-Deek HEM; Ahmed AM; Mohammed RAA
    Ann Diagn Pathol; 2019 Feb; 38():138-144. PubMed ID: 30597358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
    Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
    J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of BACH1 inhibits invasion and migration of prostate cancer cells by altering metastasis-related gene expression.
    Shajari N; Davudian S; Kazemi T; Mansoori B; Salehi S; Khaze Shahgoli V; Shanehbandi D; Mohammadi A; Duijf PHG; Baradaran B
    Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1495-1504. PubMed ID: 28889753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic and transcriptional dysregulation of VWA2 associated with a MYC-driven oncogenic program in colorectal cancer.
    González B; Fece de la Cruz F; Samuelsson JK; Alibés A; Alonso S
    Sci Rep; 2018 Jul; 8(1):11097. PubMed ID: 30038405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological Inhibition of Core Regulatory Circuitry Liquid-liquid Phase Separation Suppresses Metastasis and Chemoresistance in Osteosarcoma.
    Lu B; Zou C; Yang M; He Y; He J; Zhang C; Chen S; Yu J; Liu KY; Cao Q; Zhao W
    Adv Sci (Weinh); 2021 Oct; 8(20):e2101895. PubMed ID: 34432948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HOXD8 exerts a tumor-suppressing role in colorectal cancer as an apoptotic inducer.
    Mansour MA; Senga T
    Int J Biochem Cell Biol; 2017 Jul; 88():1-13. PubMed ID: 28457970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling.
    Yang MH; Zhao L; Wang L; Ou-Yang W; Hu SS; Li WL; Ai ML; Wang YQ; Han Y; Li TT; Ding YQ; Wang S
    Mol Cancer; 2019 Mar; 18(1):31. PubMed ID: 30823921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knock-Down of HOXB8 Prohibits Proliferation and Migration of Colorectal Cancer Cells via Wnt/β-Catenin Signaling Pathway.
    Li X; Lin H; Jiang F; Lou Y; Ji L; Li S
    Med Sci Monit; 2019 Jan; 25():711-720. PubMed ID: 30677006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional network analysis identifies BACH1 as a master regulator of breast cancer bone metastasis.
    Liang Y; Wu H; Lei R; Chong RA; Wei Y; Lu X; Tagkopoulos I; Kung SY; Yang Q; Hu G; Kang Y
    J Biol Chem; 2012 Sep; 287(40):33533-44. PubMed ID: 22875853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells.
    Shah M; Rennoll SA; Raup-Konsavage WM; Yochum GS
    Cell Cycle; 2015; 14(3):323-32. PubMed ID: 25659031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BACH1 Promotes Pancreatic Cancer Metastasis by Repressing Epithelial Genes and Enhancing Epithelial-Mesenchymal Transition.
    Sato M; Matsumoto M; Saiki Y; Alam M; Nishizawa H; Rokugo M; Brydun A; Yamada S; Kaneko MK; Funayama R; Ito M; Kato Y; Nakayama K; Unno M; Igarashi K
    Cancer Res; 2020 Mar; 80(6):1279-1292. PubMed ID: 31919242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HOXB8 promotes tumor metastasis and the epithelial-mesenchymal transition via ZEB2 targets in gastric cancer.
    Ding WJ; Zhou M; Chen MM; Qu CY
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):385-397. PubMed ID: 27761656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BACH1 silencing by siRNA inhibits migration of HT-29 colon cancer cells through reduction of metastasis-related genes.
    Davudian S; Shajari N; Kazemi T; Mansoori B; Salehi S; Mohammadi A; Shanehbandi D; Shahgoli VK; Asadi M; Baradaran B
    Biomed Pharmacother; 2016 Dec; 84():191-198. PubMed ID: 27657827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of MYC-regulated long noncoding RNAs in cell cycle regulation and tumorigenesis.
    Kim T; Jeon YJ; Cui R; Lee JH; Peng Y; Kim SH; Tili E; Alder H; Croce CM
    J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25663692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of smooth muscle-specific gene expression by homeodomain proteins, Hoxa10 and Hoxb8.
    El-Mounayri O; Triplett JW; Yates CW; Herring BP
    J Biol Chem; 2005 Jul; 280(27):25854-63. PubMed ID: 15886193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levels.
    Ding C; Luo J; Fan X; Li L; Li S; Wen K; Feng J; Wu G
    J Exp Clin Cancer Res; 2017 Apr; 36(1):56. PubMed ID: 28420432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo mutagenesis of the Hoxb8 hexapeptide domain leads to dominant homeotic transformations that mimic the loss-of-function mutations in genes of the Hoxb cluster.
    Medina-Martínez O; Ramírez-Solis R
    Dev Biol; 2003 Dec; 264(1):77-90. PubMed ID: 14623233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FoxO3a confers cetuximab resistance in RAS wild-type metastatic colorectal cancer through c-Myc.
    Yu Y; Guo M; Wei Y; Yu S; Li H; Wang Y; Xu X; Cui Y; Tian J; Liang L; Peng K; Liu T
    Oncotarget; 2016 Dec; 7(49):80888-80900. PubMed ID: 27825133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.